NEW

Pharmaceutical market in the China region

China’s pharmaceutical market is one of the most attractive markets in the Asia Pacific region for multinational investment due to the government’s widespread healthcare reforms. With a population of 1.43 billion, the Chinese pharmaceutical market is estimated to reach $206.6 billion by 2025.

Well-established local manufacturing attracts global interest

Well-established and strong local manufacturing with an international export profile

Plans to increase the pharmaceutical manufacturing industry, including the production of active pharmaceutical ingredients.

Growing disease burden, universal healthcare and government support creates local market demand

Large and increasing burden of disease suggests a significant unmet demand for pharmaceuticals

Established and expanding universal healthcare scheme, resulting in improved access to healthcare.

Strong private hospital sector growth, reflecting the ongoing modernization of the healthcare industry.

Progressive reforms introduced by the government in recent years have expanded access to healthcare.

Want to know more? Don’t miss out on featured suppliers, product information and industry news from the China market below.

Each year CPHI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market. Hosting events in Europe, China, Korea, India, Japan, South East Asia, Middle East and North America, CPHI co-locates with ICSE for contract services, P-MEC for machinery, equipment and technology, InnoPack for pharmaceutical packaging, Bioproduction for biopharma and FDF for every aspect of the finished dosage supply chain.